Evidence map›Paper›PMID 34926199›Full record

ArticleInternational journal of ophthalmology2021

Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma.

Rui Liu, Nan Wang, Hong Zhang, Xin Ge, Jian-Min Ma

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Adenoid Cystic Carcinoma of the Lacrimal Gland.Journal of current ophthalmology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rui LiuBeijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Ophthalmology & Vision Science Key Lab, Capital Medical University, Beijing 100730, China.
Nan WangBeijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Ophthalmology & Vision Science Key Lab, Capital Medical University, Beijing 100730, China.
Hong ZhangBeijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Ophthalmology & Vision Science Key Lab, Capital Medical University, Beijing 100730, China.
Xin GeBeijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Ophthalmology & Vision Science Key Lab, Capital Medical University, Beijing 100730, China.
Jian-Min MaBeijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing Ophthalmology & Vision Science Key Lab, Capital Medical University, Beijing 100730, China.
Beijing Tongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo monitor the prognosis of patients with lacrimal gland pleomorphic adenoma (LGPA) following surgical resection within the past 10y. The factors affecting patient prognosis are analyzed and the experience of surgical treatment is summarized.

methodsIn this retrospective, comparative case series, clinical records from 109 cases of LGPA treated chiefly at the same institution between November 2009 and May 2019 were reviewed. All 109 patients underwent surgery, histopathological examination, and imaging examination. For patients who underwent surgery for the first time, LGPA could be resected completely, including tumor and capsule tissues, using a surgical approach

resultsThe ratio of males to females was 1:1.60, the ages ranged from 19 to 74 years old with a mean age of 43.64±13.07 years old, and the ratio of left to right eyes was 1:1.37. A total of 109 patients underwent surgical excision and five of these received radiotherapy after malignant transformation. Of these patients, 15 were lost to follow up within the April 1, 2020 deadline and 1 was diagnosed as a recurring pathology. The 5-year recurrence rate for 86 patients who underwent initial surgery was 7.27%. Single factor analysis revealed that the course of disease, bone destruction, invasion of surrounding tissues, tumor size, capsule integrity, and expression of Ki-67 were statistically significant (

conclusionLGPA has a risk of recurrence and potential for malignant transformation. Complete removal of the tumor and capsule in the initial surgery is a key factor in preventing recurrence.

Indexed as

lacrimal glandmalignant transformationpleomorphic adenomaprognosistreatment

Identifiers

PMID34926199
PMCPMC8640764
OpenAlexW3214763151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.